reported that GLP-2 analog GLP-2G genetically fused to protein polymers called XTEN has a greatly improved half-life (240 h) and lower dose requirements in a rat model of indomethacin-induced inflammation
The limitation is that even a clear mechanism does not automatically answer route, formulation, translation, or safety questions
Results were expressed as means.e.m
After the first 24 h of incubation, no hydrolytic activity of the two assayed enzymes was detected in the supernatant containing the untreated cells, but activity was detected in the supernatant containing the cells treated by PEF
207.3 PROtocols matter: A systematised evaluation of adherence to Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) patient-reported outcome guidelines in interventional paediatric oncology trials Denise Connolly 1 , Sarah Cohen-Gogo 1 , Sharon De Graves 2 1 The Hospital for Sick Children, Toronto, Ontario, Canada, 2 University of Melbourne, Melbourne, Australia Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :207.3 Aims Despite increasing recognition of their importance, patient-reported outcomes (PROs) remain poorly implemented in interventional paediatric oncology trials
: